Page last updated: 2024-10-27

gentamicin and Cholangiocellular Carcinoma

gentamicin has been researched along with Cholangiocellular Carcinoma in 2 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sharad, N1
Srivastava, S1
Ningombam, A1
Malhotra, R1
Mathur, P1
Riedlinger, D1
Bahra, M1
Boas-Knoop, S1
Lippert, S1
Bradtmöller, M1
Guse, K1
Seehofer, D1
Bova, R1
Sauer, IM1
Neuhaus, P1
Koch, A1
Kamphues, C1

Other Studies

2 other studies available for gentamicin and Cholangiocellular Carcinoma

ArticleYear
    Infectious disorders drug targets, 2023, Volume: 23, Issue:6

    Topics: Agar; Animals; Anti-Bacterial Agents; Bacteria; Biliary Tract; Cattle; Cholangiocarcinoma; Drug Resi

2023
Hedgehog pathway as a potential treatment target in human cholangiocarcinoma.
    Journal of hepato-biliary-pancreatic sciences, 2014, Volume: 21, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Animals; Benzamides; Bile Duct Neoplasms; Bile Ducts, Intrahepatic;

2014